Scholarlink

<p>Leukocyte telomere length (LTL) is a widely studied biomarker of biological aging, reflecting cumulative cellular damage beyond chronological age. However, its prognostic relevance in clinically complex populations such as hospitalized older adults remains uncertain. In this prospective observational study, 872 patients aged ≥ 65&#xa0;years admitted to acute care wards of IRCCS INRCA within the Report-AGE cohort were included. LTL was measured by quantitative real-time PCR and expressed as age-adjusted residuals derived from an external reference population. The primary outcome was 10-year all-cause mortality. Associations between LTL residuals and mortality were assessed using Cox proportional hazards models, both&#xa0;as continuous variables and using a data-driven cut-point. Multivariable models adjusted for demographic characteristics, comorbidity burden, laboratory parameters, and polypharmacy were used. Effect modification by frailty was evaluated through interaction and stratified analyses. Over a median follow-up of 126.8&#xa0;months, 713 patients died. Shorter age-adjusted LTL was associated with increased mortality risk in univariable analysis (HR per 1 SD decrease = 1.10, 95% CI 1.02–1.19; <i>p</i> = 0.012). When dichotomized using an optimal cut-point, patients with shorter-than-expected telomeres exhibited significantly higher mortality (adjusted HR = 1.30, 95% CI 1.05–1.60; <i>p</i> = 0.016), regardless of clinical and laboratory covariates. A significant interaction with frailty was observed (<i>p</i> for interaction = 0.031), with the association between LTL and mortality being evident among patients without frailty. Age-adjusted LTL provides independent prognostic information in hospitalized older adults and may reflect biologically meaningful heterogeneity associated with aging, particularly among individuals without frailty.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Age-adjusted leukocyte telomere length predicts long-term mortality in older patients discharged from acute care hospitals

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月25日

查看全文
  • Rosanna Maniscalco,
  • Deborah Ramini,
  • Mirko Di Rosa,
  • Maurizio Cardelli,
  • Rina Recchioni,
  • Francesca Marchegiani,
  • Francesco Piacenza,
  • Robertina Giacconi,
  • Chiara Giordani,
  • Giulia Matacchione,
  • Matilde Sbriscia,
  • Sonia Fantone,
  • Stefania Fumarola,
  • Salvatore Vaiasicca,
  • Monia Cecati,
  • Adrianapia Maria Lamedica,
  • Leonardo Biscetti,
  • Antonio Cherubini,
  • Francesco Spannella,
  • Luca Soraci,
  • Anna Rita Bonfigli,
  • Fabrizia Lattanzio,
  • Jacopo Sabbatinelli,
  • Fabiola Olivieri,
  • Angelica Giuliani

摘要

Leukocyte telomere length (LTL) is a widely studied biomarker of biological aging, reflecting cumulative cellular damage beyond chronological age. However, its prognostic relevance in clinically complex populations such as hospitalized older adults remains uncertain. In this prospective observational study, 872 patients aged ≥ 65 years admitted to acute care wards of IRCCS INRCA within the Report-AGE cohort were included. LTL was measured by quantitative real-time PCR and expressed as age-adjusted residuals derived from an external reference population. The primary outcome was 10-year all-cause mortality. Associations between LTL residuals and mortality were assessed using Cox proportional hazards models, both as continuous variables and using a data-driven cut-point. Multivariable models adjusted for demographic characteristics, comorbidity burden, laboratory parameters, and polypharmacy were used. Effect modification by frailty was evaluated through interaction and stratified analyses. Over a median follow-up of 126.8 months, 713 patients died. Shorter age-adjusted LTL was associated with increased mortality risk in univariable analysis (HR per 1 SD decrease = 1.10, 95% CI 1.02–1.19; p = 0.012). When dichotomized using an optimal cut-point, patients with shorter-than-expected telomeres exhibited significantly higher mortality (adjusted HR = 1.30, 95% CI 1.05–1.60; p = 0.016), regardless of clinical and laboratory covariates. A significant interaction with frailty was observed (p for interaction = 0.031), with the association between LTL and mortality being evident among patients without frailty. Age-adjusted LTL provides independent prognostic information in hospitalized older adults and may reflect biologically meaningful heterogeneity associated with aging, particularly among individuals without frailty.